372 related articles for article (PubMed ID: 23122981)
1. Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma.
Yang H; Hu W; Wang W; Chen P; Ding W; Luo W
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e47-54. PubMed ID: 23122981
[TBL] [Abstract][Full Text] [Related]
2. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.
Luo Y; Qin Y; Lang J
Clin Transl Oncol; 2017 Apr; 19(4):470-476. PubMed ID: 27718153
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial.
Yang H; Chen X; Lin S; Rong J; Yang M; Wen Q; Shang C; He L; Ren P; Xu S; Zhang J; Liu Q; Pang H; Shi X; Fan J; Sun X; Ma D; Tan B; Zhang T; Zhang L; Hu D; Du X; Zhang Y; Wen S; Zhang X; Wu J
Radiother Oncol; 2018 Jan; 126(1):37-42. PubMed ID: 28864073
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of replanning during intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: An updated and expanded retrospective analysis.
Zhou X; Wang W; Zhou C; Zhu J; Ding W; Chen M; Chen K; Shi Y; Chen X; Kong FM; Yang H
Radiother Oncol; 2022 May; 170():136-142. PubMed ID: 35288229
[TBL] [Abstract][Full Text] [Related]
5. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
[TBL] [Abstract][Full Text] [Related]
6. The role of replanning in fractionated intensity modulated radiotherapy for nasopharyngeal carcinoma.
Zhao L; Wan Q; Zhou Y; Deng X; Xie C; Wu S
Radiother Oncol; 2011 Jan; 98(1):23-7. PubMed ID: 21040992
[TBL] [Abstract][Full Text] [Related]
7. Clinical study of the necessity of replanning before the 25th fraction during the course of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.
Wang W; Yang H; Hu W; Shan G; Ding W; Yu C; Wang B; Wang X; Xu Q
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):617-21. PubMed ID: 20138444
[TBL] [Abstract][Full Text] [Related]
8. Using neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissue.
Niu X; Chang X; Gao Y; Hu C; Kong L
Radiat Oncol; 2013 Oct; 8():226. PubMed ID: 24083351
[TBL] [Abstract][Full Text] [Related]
9. Predictors for replanning in loco-regionally advanced nasopharyngeal carcinoma patients undergoing intensity-modulated radiation therapy: a prospective observational study.
Yan D; Yan S; Wang Q; Liao X; Lu Z; Wang Y
BMC Cancer; 2013 Nov; 13():548. PubMed ID: 24237861
[TBL] [Abstract][Full Text] [Related]
10. Assessment of anatomical and dosimetric changes by a deformable registration method during the course of intensity-modulated radiotherapy for nasopharyngeal carcinoma.
Lu J; Ma Y; Chen J; Wang L; Zhang G; Zhao M; Yin Y
J Radiat Res; 2014 Jan; 55(1):97-104. PubMed ID: 23728319
[TBL] [Abstract][Full Text] [Related]
11. Clinical study of the time of repeated computed tomography and replanning for patients with nasopharyngeal carcinoma.
Gai X; Wei Y; Tao H; Zhu J; Li B
Oncotarget; 2017 Apr; 8(16):27529-27540. PubMed ID: 28404877
[TBL] [Abstract][Full Text] [Related]
12. Failure patterns of locoregional recurrence after reducing target volumes in patients with nasopharyngeal carcinoma receiving adaptive replanning during intensity-modulated radiotherapy: a single-center experience in China.
Zhou X; Zhu J; Zhou C; Wang W; Ding W; Chen M; Chen K; Li S; Chen X; Yang H
Radiat Oncol; 2023 Nov; 18(1):190. PubMed ID: 37974274
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiotherapy provides better quality of life than two-dimensional conventional radiotherapy for patients with stage II nasopharyngeal carcinoma.
Pan XB; Huang ST; Chen KH; Jiang YM; Ma JL; Qu S; Li L; Chen L; Zhu XD
Oncotarget; 2017 Jul; 8(28):46211-46218. PubMed ID: 28515352
[TBL] [Abstract][Full Text] [Related]
14. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer.
Hansen EK; Bucci MK; Quivey JM; Weinberg V; Xia P
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):355-62. PubMed ID: 16256277
[TBL] [Abstract][Full Text] [Related]
15. SU-E-T-550: Influence of the Clinical Outcome and Quality of Life by Replanning during Intensity-Modulated Radiation Therapy for Nasopharyngeal Carcinoma.
Yang H; Hu W; Wang W; Chen P
Med Phys; 2012 Jun; 39(6Part18):3832. PubMed ID: 28518508
[TBL] [Abstract][Full Text] [Related]
16.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
17. Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical Trial.
Tang LL; Guo R; Zhang N; Deng B; Chen L; Cheng ZB; Huang J; Hu WH; Huang SH; Luo WJ; Liang JH; Zheng YM; Zhang F; Mao YP; Li WF; Zhou GQ; Liu X; Chen YP; Xu C; Lin L; Liu Q; Du XJ; Zhang Y; Sun Y; Ma J
JAMA; 2022 Aug; 328(8):728-736. PubMed ID: 35997729
[TBL] [Abstract][Full Text] [Related]
18. Clinical Outcome and Prognostic Factors of Intensity-Modulated Radiotherapy for T4 Stage Nasopharyngeal Carcinoma.
Luo Y; Gao Y; Yang G; Lang J
Biomed Res Int; 2016; 2016():4398498. PubMed ID: 27195286
[TBL] [Abstract][Full Text] [Related]
19. Is it necessary to repeat CT imaging and replanning during the course of intensity-modulated radiation therapy for locoregionally advanced nasopharyngeal carcinoma?
Chen C; Lin X; Pan J; Fei Z; Chen L; Bai P
Jpn J Radiol; 2013 Sep; 31(9):593-9. PubMed ID: 23749480
[TBL] [Abstract][Full Text] [Related]
20. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy.
Huang TL; Chien CY; Tsai WL; Liao KC; Chou SY; Lin HC; Dean Luo S; Lee TF; Lee CH; Fang FM
Head Neck; 2016 Apr; 38 Suppl 1():E1026-32. PubMed ID: 26041548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
